MyMD Pharmaceuticals Inc. (NASDAQ: MYMD)
$1.91
+0.1000 ( +5.53% ) 34.2K
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-1R is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.
Market Data
Open
$1.91
Previous close
$1.81
Volume
34.2K
Market cap
$4.50M
Day range
$1.74 - $1.93
52 week range
$1.74 - $63.90
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 31, 2023 |
8-k | 8K-related | 12 | Jul 14, 2023 |